electroCore (ECOR) FCF Margin Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1,716.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,811.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,833.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 192.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 261.00 |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | 3,396.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,396.00 |
| Dec 31, 2025 | -1,810.00 |
| Sep 30, 2025 | 13,322.00 |
| Jun 30, 2025 | -3,647.00 |
| Mar 31, 2025 | -11,313.00 |
| Dec 31, 2024 | 11,787.00 |
| Sep 30, 2024 | -20,185.00 |
| Jun 30, 2024 | -39,641.00 |
| Mar 31, 2024 | 25,856.00 |
| Dec 31, 2023 | 21,765.00 |
| Sep 30, 2023 | 28,253.00 |
| Jun 30, 2023 | 57,450.00 |
| Mar 31, 2023 | 4,092.00 |
| Dec 31, 2022 | 13,522.00 |
| Sep 30, 2022 | -134.00 |
| Jun 30, 2022 | 63,968.00 |
| Mar 31, 2022 | -60,055.00 |
| Dec 31, 2021 | -423,160.00 |
| Sep 30, 2021 | 13,446.00 |
| Jun 30, 2021 | -25,608.00 |
| Mar 31, 2021 | 150,591.00 |
| Dec 31, 2020 | 528,939.00 |
| Sep 30, 2020 | 83,968.00 |
| Jun 30, 2020 | 128,888.00 |
| Mar 31, 2020 | 285,597.00 |
| Dec 31, 2019 | 195,941.00 |
| Sep 30, 2019 | 807,573.00 |
| Jun 30, 2019 | 107,020.00 |
| Mar 31, 2019 | 808,536.00 |
| Dec 31, 2018 | 15,153.00 |
| Sep 30, 2018 | -694,891.00 |